These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10657247)

  • 1. A general kinetic approach to investigation of active-site availability in macromolecular catalysts.
    Resmini M; Gul S; Carter S; Sonkaria S; Topham CM; Gallacher G; Brocklehurst K
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):117-25. PubMed ID: 10657247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and titration methods for determination of active site contents of enzyme and catalytic antibody preparations.
    Brocklehurst K; Resmini M; Topham CM
    Methods; 2001 Jun; 24(2):153-67. PubMed ID: 11384190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetic basis of a general method for the investigation of active site content of enzymes and catalytic antibodies: first-order behaviour under single-turnover and cycling conditions.
    Topham CM; Gul S; Resmini M; Sonkaria S; Gallacher G; Brocklehurst K
    J Theor Biol; 2000 May; 204(2):239-56. PubMed ID: 10887904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition state.
    Gallacher G; Jackson CS; Searcey M; Goel R; Mellor GW; Smith CZ; Brocklehurst K
    Eur J Biochem; 1993 May; 214(1):197-207. PubMed ID: 8508792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of modulated structural dynamics on the kinetics of alpha-chymotrypsin catalysis. Insights through chemical glycosylation, molecular dynamics and domain motion analysis.
    Solá RJ; Griebenow K
    FEBS J; 2006 Dec; 273(23):5303-19. PubMed ID: 17076704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polyclonal antibody preparation with Michaelian catalytic properties.
    Gallacher G; Jackson CS; Searcey M; Badman GT; Goel R; Topham CM; Mellor GW; Brocklehurst K
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):871-81. PubMed ID: 1953683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic reaction of silent substrates: kinetic theory and application to the serine protease chymotrypsin.
    Case A; Huskey WP; Stein RL
    Biochemistry; 2003 Apr; 42(16):4727-32. PubMed ID: 12705836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal antibody catalytic variability.
    Stephens DB; Thomas RE; Stanton JF; Iverson BL
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):127-34. PubMed ID: 9576860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An active immunization approach to generate protective catalytic antibodies.
    Wang J; Han Y; Wilkinson MF
    Biochem J; 2001 Nov; 360(Pt 1):151-7. PubMed ID: 11696002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving-group determinant: evidence for the 'flexibility' hypothesis.
    Gul S; Sonkaria S; Pinitglang S; Florez-Alvarez J; Hussain S; Thomas EW; Ostler EL; Gallacher G; Resmini M; Brocklehurst K
    Biochem J; 2003 Dec; 376(Pt 3):813-21. PubMed ID: 12946271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of active-site residues in the catalytic mechanism of trans-3-chloroacrylic acid dehalogenase: a kinetic, NMR, and mutational analysis.
    Azurmendi HF; Wang SC; Massiah MA; Poelarends GJ; Whitman CP; Mildvan AS
    Biochemistry; 2004 Apr; 43(14):4082-91. PubMed ID: 15065850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active centre studies on bovine pancreatic chymotrypsin with tripeptidyl-p-nitroanilide substrates.
    Tözsér J; Szabó G; Pozsgay M; Aurell L; Elödi P
    Acta Biochim Biophys Hung; 1986; 21(4):335-48. PubMed ID: 3109178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune recognition, antigen design, and catalytic antibody production.
    Tramontano A
    Appl Biochem Biotechnol; 1994; 47(2-3):257-73; discussion 273-5. PubMed ID: 7944342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for 'lock and key' character in an anti-phosphonate hydrolytic antibody catalytic site augmented by non-reaction centre recognition: variation in substrate selectivity between an anti-phosphonate antibody, an anti-phosphate antibody and two hydrolytic enzymes.
    Sonkaria S; Boucher G; Flórez-Olvarez J; Said B; Hussain S; Ostler EL; Gul S; Thomas EW; Resmini M; Gallacher G; Brocklehurst K
    Biochem J; 2004 Jul; 381(Pt 1):125-30. PubMed ID: 15053743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive immunization.
    Wirsching P; Ashley JA; Lo CH; Janda KD; Lerner RA
    Science; 1995 Dec; 270(5243):1775-82. PubMed ID: 8525366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic characterization of the chymotryptic activity of the 20S proteasome.
    Stein RL; Melandri F; Dick L
    Biochemistry; 1996 Apr; 35(13):3899-908. PubMed ID: 8672420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for a disfavored elimination reaction in catalytic antibody 1D4.
    Larsen NA; Heine A; Crane L; Cravatt BF; Lerner RA; Wilson IA
    J Mol Biol; 2001 Nov; 314(1):93-102. PubMed ID: 11724535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of protein conformational mobility in enzyme catalysis: acylation of alpha-chymotrypsin by specific peptide substrates.
    Hengge AC; Stein RL
    Biochemistry; 2004 Jan; 43(3):742-7. PubMed ID: 14730979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.